Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionMascoma Wealth Management LLC
Latest Disclosed Ownership67 shares
Latest Disclosed Value $ 10,234
Mascoma Wealth Management LLC ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 30, 2026 - Mascoma Wealth Management LLC filed a 13F-HR form disclosing ownership of 67 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $10,234 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 67 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $9,625 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 10 11.11 0.0021
2026-02-04 2025-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 9 12.50 0.0020
2025-10-28 2025-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 9 0.00 0.0019
2025-07-22 2025-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 8 14.29 0.0019
2025-04-24 2025-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 16.67 0.0019
2025-02-10 2024-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 -14.29 0.0016
2024-11-05 2024-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 8 0.00 0.0019
2024-08-02 2024-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 16.67 0.0019
2024-05-02 2024-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 6 0.00 0.0018
2024-01-24 2023-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 0.00 0.0020
2023-10-13 2023-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 0.00 0.0021
2023-08-09 2023-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 0.00 0.0021
2023-05-01 2023-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 7 0.00 0.0020
2023-01-24 2022-12-31 13F/A-1 NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 6 20.00 0.0019
2023-01-20 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0 0.0017
2022-10-18 2022-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 5 -16.67 0.0017
2022-07-14 2022-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 0 0.00 6 0.00 0.0021
2022-04-25 2022-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 67 67 6 0.0019
2019-04-23 2019-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 0 -40 -100.00 0 -100.00
2019-01-28 2018-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 40 0 0.00 3 0.00 0.0023
2018-11-08 2018-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 40 0 0.00 3 0.00 0.0020
2018-08-13 2018-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 40 0 0.00 3 0.00 0.0021
2018-04-24 2018-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 40 -60 -60.00 3 -66.67 0.0020
2018-02-05 2017-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 100 -400 -80.00 9 -79.07 0.0055
2017-11-07 2017-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 500 0 0.00 43 2.38 0.0287
2017-07-13 2017-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 500 200 66.67 42 90.91 0.0283
2017-04-18 2017-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 300 0 0.00 22 0.00 0.0158
2017-01-30 2016-12-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 300 300 22 0.0162
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.